Amicus Therapeutics Stock Tumbles After FDA Setback
November 30, 2016 at 11:52 AM EST
Amicus Therapeutics stock tumbled on Tuesday after it had announced a major setback. The problem is that the company hoped that it could seek marketing approval for its Fabry disease drug Galafold in the coming months.
